CTRI/2018/01/011149已完成未知
A randomized, double blind, placebo controlled, parallel group study to evaluate the Safety and Efficacy of Asafin in patients with non- ulcer functional Dyspepsia
Akay Flavours and Aromatics Private Limited0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Age 25-55 Years ( Both Inclusive)
- •2.Male and Female Subjects
- •3.Fulfilling Rome III Diagnostic Criteria for Functional Dyspepsia
- •4.Subject Willing To give written Informed consent
排除标准
- •1.History of Peptic ulcer, Gastro oesophageal Reflux Disease, Gastro Intestinal surgery or any other clinically significant gastro intestinal disease.
- •2.Psychiatric illness
- •3.Pregnant or Lactating women.
- •4.History of Congestive Heart Failure or uncontrolled hypertension
- •5.Subjects with abnormal hematological or Biochemical Parameters
- •6.Subjects who have taken antibiotics or any other drugs in last 2 weeks whose primary site of action is in the GIT-.
- •7.Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.
研究者
相似试验
进行中（未招募）
不适用
A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors - Permanent Atrial fibriLLAtion outcome Study using Dronedarone on top of standard therapy (PALLAS)MedDRA version: 14.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersAtrial FibrillationEUCTR2010-019791-73-DESanofi-aventis recherche & développement10,800
进行中（未招募）
1 期
Investigate the safety and efficacy of study drug ABX464 compared with placebo in patients with moderate to severe ulcerative colitis who have failed to other treatments.Moderate to Severe Ulcerative ColitisMedDRA version: 20.1Level: LLTClassification code 10066678Term: Acute ulcerative colitisSystem Organ Class: 100000004856EUCTR2018-003558-26-CZABIVAX232
进行中（未招募）
不适用
A randomized, double blind, placebo controlled, parallel groups, pilot study to assess the effects of two new nail lacquers, cyclosporine 5% and calcipotriol 0.005%, in the treatment of nail psoriasis - NDail psoriasisMedDRA version: 9.1Level: LLTClassification code 10028703EUCTR2010-019706-16-ITPOLICHEM
进行中（未招募）
不适用
A randomized, double blind, placebo controlled, parallel group, multicenter study of the safety and response rate of 3 subcutaneously administered doses of 5x10E7pfu RO5217790 in patients with high grade cervical intraepithelial neoplasia grade 2 or 3 associated with High Risk HPV infectioHigh grade cervical intraepithelial neoplasia grade 2 or 3 associated with High Risk HPV infectionMedDRA version: 9.1Level: LLTClassification code 10049701Term: Cervical intraepithelial neoplasia IIMedDRA version: 9.1Level: LLTClassification code 10049702Term: Cervical intraepithelial neoplasia IIIEUCTR2008-006946-24-DEF. Hoffmann-La Roche Ltd200
进行中（未招募）
不适用
A clinical study evaluating two different nail lacquers containing cyclosporine 5% and calcipotriol 0.005% in the treatment of nail psoriasis. A placebo (no active compound) will be used as control. Nor the investigator nor the patient will know the treatment applied.ail psoriasis of the nail matrix and / or the nail bed at fingernails (at least one should be affected)EUCTR2010-019706-16-LVPolichem SA75